Last reviewed · How we verify
Adenovite (ADENOSINE PHOSPHATE)
Adenovite, a marketed drug by an unspecified company, activates adenosine receptors to treat cystic fibrosis of the lung. Its key strength lies in its mechanism of reducing inflammation and slowing disease progression, setting it apart in the treatment landscape. The primary risk is the competition from disulfiram, an off-patent drug with the same target, which may limit Adenovite's market share.
At a glance
| Generic name | ADENOSINE PHOSPHATE |
|---|---|
| Drug class | Adenosine Receptor Agonist |
| Target | Proto-oncogene tyrosine-protein kinase Src |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Approved indications
- Cystic fibrosis of the lung
Common side effects
Key clinical trials
- Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma (PHASE2)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders (PHASE2)
- NAD+ Oral Supplement Pilot Intervention in Adult Females (NA)
- Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer (PHASE1,PHASE2)
- Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders (PHASE2)
- Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS (PHASE2,PHASE3)
- A Phase 1b Study of Adenylosuccinic Acid (ASA-001) for Adenylosuccinate Synthase 1 (ADSS1) Deficient Myopathy. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adenovite CI brief — competitive landscape report
- Adenovite updates RSS · CI watch RSS